How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice

The management of chronic myeloid leukemia (CML) has remarkably changed in the last 20 years with the availability of tyrosine kinase inhibitors (TKI). Most patients with chronic phase CML now have a life expectancy like that of age matched controls. Understanding the practical aspects of choosing t...

Descripción completa

Detalles Bibliográficos
Autor principal: Guru Murthy, Guru Subramanian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943651/
https://www.ncbi.nlm.nih.gov/pubmed/35340664
http://dx.doi.org/10.2147/BLCTT.S219160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943651/
https://www.ncbi.nlm.nih.gov/pubmed/35340664
http://dx.doi.org/10.2147/BLCTT.S219160

Ejemplares similares